Champions Oncology, Inc. (CSBR) Q3 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Champions Oncology, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.880 Greetings. Welcome to the Champions Oncology third quarter fiscal year 2026 earnings 00:00:05.880 -- 00:00:10.207 call. At this time, all participants are in a listen-only mode. 00:00:10.207 -- 00:00:13.351 A question and answer session will follow the formal presentation. 00:00:13.351 -- 00:00:16.997 If anyone should require operator assistance during the conference, please press star 00:00:16.997 -- 00:00:21.804 zero on your telephone keypad. Please note this conference is being recorded. 00:00:21.804 -- 00:00:26.271 I will now turn the conference over to your host, Rob Braynon, CEO at Champions Oncology. 00:00:26.271 -- 00:00:28.552 You may begin. 00:00:29.005 -- 00:00:33.731 Good afternoon, and thank you for joining us for our third quarter fiscal 2026 earnings 00:00:33.731 -- 00:00:39.019 call. I'm Rob Brayman, CEO of Champions Oncology, and I'm joined today by our CFO, David 00:00:39.019 -- 00:00:44.246 Miller. Before we begin, I'll remind everyone that today's remarks may include forward-looking 00:00:44.246 -- 00:00:49.473 statements. Actual results may differ materially, and additional information can be found 00:00:49.473 -- 00:00:51.989 in our filings with the SEC. 00:00:51.989 -- 00:00:56.255 Before I walk through the quarter, let me briefly highlight three key takeaways. 00:00:56.255 -- 00:01:01.021 First, we delivered another quarter of strong operational performance, including record 00:01:01.021 -- 00:01:06.047 services revenue and our third consecutive quarter of positive adjusted EBITDA. 00:01:06.047 -- 00:01:10.593 Second, while quarterly revenue can fluctuate in our business, we remain on track for 00:01:10.593 -- 00:01:15.259 full-year revenue growth and full-year positive adjusted EBITDA, while continuing to 0...